- Home
- ACET vs PODC Comparison
ACET vs PODC Comparison
Compare ACET & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- PODC
- Stock Information
- Founded
- ACET 1947
- PODC 2013
- Country
- ACET United States
- PODC United States
- Employees
- ACET N/A
- PODC N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- PODC
- Sector
- ACET Health Care
- PODC
- Exchange
- ACET Nasdaq
- PODC Nasdaq
- Market Cap
- ACET 44.4M
- PODC 44.1M
- IPO Year
- ACET N/A
- PODC N/A
- Fundamental
- Price
- ACET $0.60
- PODC $1.81
- Analyst Decision
- ACET Buy
- PODC Strong Buy
- Analyst Count
- ACET 6
- PODC 1
- Target Price
- ACET $6.00
- PODC $5.00
- AVG Volume (30 Days)
- ACET 523.1K
- PODC 30.8K
- Earning Date
- ACET 05-13-2025
- PODC 05-29-2025
- Dividend Yield
- ACET N/A
- PODC N/A
- EPS Growth
- ACET N/A
- PODC N/A
- EPS
- ACET N/A
- PODC N/A
- Revenue
- ACET N/A
- PODC $49,729,000.00
- Revenue This Year
- ACET N/A
- PODC $20.67
- Revenue Next Year
- ACET N/A
- PODC $19.09
- P/E Ratio
- ACET N/A
- PODC N/A
- Revenue Growth
- ACET N/A
- PODC 22.98
- 52 Week Low
- ACET $0.45
- PODC $1.10
- 52 Week High
- ACET $2.08
- PODC $2.85
- Technical
- Relative Strength Index (RSI)
- ACET 43.47
- PODC 51.83
- Support Level
- ACET $0.51
- PODC $1.63
- Resistance Level
- ACET $0.61
- PODC $1.99
- Average True Range (ATR)
- ACET 0.07
- PODC 0.20
- MACD
- ACET 0.01
- PODC 0.02
- Stochastic Oscillator
- ACET 55.54
- PODC 59.03
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.